Laszlo Szollas, MD
Interventional Pain Medicine · East Stroudsburg, PANPI 1790880003
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,329 of the $3,184 with a category attached, or 73.1%. 25 manufacturers reported payments, led by Stryker at 31.2% of the total. That places this record below the midpoint for interventional pain medicine clinicians in PA, where the typical reported total is $2,714.
Across 173 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$994
- Boston Scientific$606
- Medtronic$327
- Collegium Pharmaceutical, Inc.$189
- Endo Pharmaceuticals Inc.$181
- Nevro Corp.$173
- plus $715 from 19 others
What the payments were for
- Travel & lodging$85527%
- Food & beverage$2,32973%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 6 | $994 |
| Boston Scientific | 84 | $606 |
| Medtronic | 4 | $327 |
| Collegium Pharmaceutical, Inc. | 27 | $189 |
| Endo Pharmaceuticals Inc. | 8 | $181 |
| Nevro Corp. | 4 | $173 |
| ERMI LLC | 3 | $81 |
| Globus Medical | 4 | $78 |
| Johnson & Johnson | 4 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $73 |
| Pfizer | 4 | $53 |
| Si-bone, Inc. | 2 | $46 |
| Novus Surgical Solutions LLC | 1 | $43 |
| Amgen | 3 | $38 |
| Bioventus LLC | 2 | $35 |
| Ferring Pharmaceuticals Inc. | 2 | $28 |
| Kaleo, Inc. | 2 | $25 |
| Organogenesis Inc. | 1 | $23 |
| Pacira Therapeutics, Inc. | 1 | $21 |
| Omeros Corporation | 1 | $19 |
| Electronic Waveform Lab, Inc. | 2 | $17 |
| Avanos Medical | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Smith+Nephew | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,184 in reported general payments places this provider in the 50th percentile of 59 interventional pain medicine providers in Pennsylvania.
See all interventional pain medicine providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 53 | $34,919 |
| OxycontinOxycodone Hcl | 43 | $24,167 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 554 | $13,403 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 536 | $12,223 |
| MovantikNaloxegol Oxalate | 23 | $9,405 |
| Buprenorphine | 30 | $6,866 |
| Gabapentin | 468 | $6,611 |
| Celecoxib | 173 | $5,059 |
| Lidocaine | 47 | $4,804 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 221 | $4,005 |
| Cyclobenzaprine Hcl | 240 | $3,958 |
| Morphine Sulfate ErMorphine Sulfate | 137 | $3,856 |
| Morphine Sulfate | 120 | $3,724 |
| Tramadol Hcl | 436 | $3,295 |
| Pregabalin | 267 | $3,048 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $189 | $34,91953 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 59 interventional pain medicine providers in Pennsylvania.
Other interventional pain medicine in East Stroudsburg
- Michael FishmanLebanon$670K
- David ProvenzanoSewickley$198K
- Michael FarrellPittsburgh$23K
- Farshad RashidianWest Chester$19K
- Chad MetzgerDarby$14K
- Jorge Rivero-BecerraPittsburgh$12K
- James BresnahanSpringfield$12K
- Jonathan SchollIndiana$11K
- Nathan MaltezosWest Chester$10K
- Mark BellPlains$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.